Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated:  11/2/2017
M.D.Anderson Cancer Center
1595
mi
from 02139
Houston, TX
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated: 11/2/2017
M.D.Anderson Cancer Center
1595
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated:  11/2/2017
Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg
mi
from 02139
Würzburg,
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated: 11/2/2017
Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg
mi
from 02139
Würzburg,
Click here to add this to my saved trials
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
A Pilot Study of Tumor Lysate-pulsed Dendritic Cell Vaccine for Immune Augmentation for High-risk Solid Tumor Patients Following Autologous Stem Cell Transplantation
Status: Enrolling
Updated:  11/2/2017
University of Michigan, Department of Surgery, Pediatric Section
645
mi
from 02139
Ann Arbor, MI
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
A Pilot Study of Tumor Lysate-pulsed Dendritic Cell Vaccine for Immune Augmentation for High-risk Solid Tumor Patients Following Autologous Stem Cell Transplantation
Status: Enrolling
Updated: 11/2/2017
University of Michigan, Department of Surgery, Pediatric Section
645
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
RCT of Strategies to Improve Screening Rates Among a Cohort of Cirrhotic Patients at High Risk for Developing HCC in a Safety-net Health System
Status: Enrolling
Updated:  11/2/2017
Parkland Health and Hospital System
1547
mi
from 02139
Dallas, TX
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
RCT of Strategies to Improve Screening Rates Among a Cohort of Cirrhotic Patients at High Risk for Developing HCC in a Safety-net Health System
Status: Enrolling
Updated: 11/2/2017
Parkland Health and Hospital System
1547
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Phase 1b Study of Extended Dosing of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer.
Status: Enrolling
Updated:  11/2/2017
Winthrop University Hospital
172
mi
from 02139
Mineola, NY
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Phase 1b Study of Extended Dosing of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer.
Status: Enrolling
Updated: 11/2/2017
Winthrop University Hospital
172
mi
from 02139
Mineola, NY
Click here to add this to my saved trials
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Phase 1b Study of Extended Dosing of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer.
Status: Enrolling
Updated:  11/2/2017
Lenox Hill Hospital
184
mi
from 02139
New York, NY
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Phase 1b Study of Extended Dosing of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer.
Status: Enrolling
Updated: 11/2/2017
Lenox Hill Hospital
184
mi
from 02139
New York, NY
Click here to add this to my saved trials
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Phase 1b Study of Extended Dosing of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer.
Status: Enrolling
Updated:  11/2/2017
Princess Margaret Cancer Centre
427
mi
from 02139
Toronto,
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Phase 1b Study of Extended Dosing of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer.
Status: Enrolling
Updated: 11/2/2017
Princess Margaret Cancer Centre
427
mi
from 02139
Toronto,
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Mayo Clinic Arizona
2275
mi
from 02139
Scottsdale, AZ
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Mayo Clinic Arizona
2275
mi
from 02139
Scottsdale, AZ
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Saint Francis Hospital and Medical Center
90
mi
from 02139
Hartford, CT
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Saint Francis Hospital and Medical Center
90
mi
from 02139
Hartford, CT
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Mayo Clinic Florida
1012
mi
from 02139
Jacksonville, FL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Mayo Clinic Florida
1012
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Rush - Copley Medical Center
882
mi
from 02139
Aurora, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Rush - Copley Medical Center
882
mi
from 02139
Aurora, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare-Bloomington
932
mi
from 02139
Bloomington, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare-Bloomington
932
mi
from 02139
Bloomington, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Saint Joseph Medical Center
932
mi
from 02139
Bloomington, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Saint Joseph Medical Center
932
mi
from 02139
Bloomington, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Graham Hospital Association
985
mi
from 02139
Canton, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Graham Hospital Association
985
mi
from 02139
Canton, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Canton
985
mi
from 02139
Canton, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Canton
985
mi
from 02139
Canton, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Carthage
1043
mi
from 02139
Carthage, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Carthage
1043
mi
from 02139
Carthage, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Memorial Hospital
1043
mi
from 02139
Carthage, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Memorial Hospital
1043
mi
from 02139
Carthage, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Saint Anthony Memorial Hospital
937
mi
from 02139
Effingham, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Saint Anthony Memorial Hospital
937
mi
from 02139
Effingham, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Eureka Hospital
944
mi
from 02139
Eureka, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Eureka Hospital
944
mi
from 02139
Eureka, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Eureka
944
mi
from 02139
Eureka, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Eureka
944
mi
from 02139
Eureka, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Galesburg Cottage Hospital
997
mi
from 02139
Galesburg, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Galesburg Cottage Hospital
997
mi
from 02139
Galesburg, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Galesburg
997
mi
from 02139
Galesburg, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Galesburg
997
mi
from 02139
Galesburg, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Western Illinois Cancer Treatment Center
997
mi
from 02139
Galesburg, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Western Illinois Cancer Treatment Center
997
mi
from 02139
Galesburg, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Havana
991
mi
from 02139
Havana, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Havana
991
mi
from 02139
Havana, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Mason District Hospital
991
mi
from 02139
Havana, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Mason District Hospital
991
mi
from 02139
Havana, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Hopedale Medical Complex - Hospital
956
mi
from 02139
Hopedale, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Hopedale Medical Complex - Hospital
956
mi
from 02139
Hopedale, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Joliet Oncology-Hematology Associates Limited
873
mi
from 02139
Joliet, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Joliet Oncology-Hematology Associates Limited
873
mi
from 02139
Joliet, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Kewanee Clinic
970
mi
from 02139
Kewanee, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Kewanee Clinic
970
mi
from 02139
Kewanee, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Kewanee Hospital
968
mi
from 02139
Kewanee, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Kewanee Hospital
968
mi
from 02139
Kewanee, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Macomb
1020
mi
from 02139
Macomb, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Macomb
1020
mi
from 02139
Macomb, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
McDonough District Hospital
1020
mi
from 02139
Macomb, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
McDonough District Hospital
1020
mi
from 02139
Macomb, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Holy Family Medical Center
1012
mi
from 02139
Monmouth, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Holy Family Medical Center
1012
mi
from 02139
Monmouth, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Monmouth
1011
mi
from 02139
Monmouth, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Monmouth
1011
mi
from 02139
Monmouth, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
BroMenn Regional Medical Center
933
mi
from 02139
Normal, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
BroMenn Regional Medical Center
933
mi
from 02139
Normal, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Community Cancer Center Foundation
933
mi
from 02139
Normal, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Community Cancer Center Foundation
933
mi
from 02139
Normal, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Community Cancer Center
933
mi
from 02139
Normal, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Community Cancer Center
933
mi
from 02139
Normal, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare-Ottawa Clinic
913
mi
from 02139
Ottawa, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare-Ottawa Clinic
913
mi
from 02139
Ottawa, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Ottawa Regional Hospital and Healthcare Center
913
mi
from 02139
Ottawa, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Ottawa Regional Hospital and Healthcare Center
913
mi
from 02139
Ottawa, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Pekin Cancer Treatment Center
965
mi
from 02139
Pekin, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Pekin Cancer Treatment Center
965
mi
from 02139
Pekin, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Pekin Hospital
965
mi
from 02139
Pekin, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Pekin Hospital
965
mi
from 02139
Pekin, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Pekin
960
mi
from 02139
Pekin, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Pekin
960
mi
from 02139
Pekin, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Methodist Medical Center of Illinois
961
mi
from 02139
Peoria, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Methodist Medical Center of Illinois
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Proctor Hospital
960
mi
from 02139
Peoria, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Proctor Hospital
960
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
OSF Saint Francis Medical Center Radiation Oncology Service at the Central Illinois Comprehensive CC
961
mi
from 02139
Peoria, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
OSF Saint Francis Medical Center Radiation Oncology Service at the Central Illinois Comprehensive CC
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare-Peoria
961
mi
from 02139
Peoria, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare-Peoria
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois Oncology Research Association CCOP
961
mi
from 02139
Peoria, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois Oncology Research Association CCOP
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
OSF Saint Francis Medical Center
961
mi
from 02139
Peoria, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
OSF Saint Francis Medical Center
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Peru
928
mi
from 02139
Peru, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Peru
928
mi
from 02139
Peru, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois Valley Hospital
928
mi
from 02139
Peru, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois Valley Hospital
928
mi
from 02139
Peru, IL
Click here to add this to my saved trials
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  11/2/2017
Illinois CancerCare - Princeton
944
mi
from 02139
Princeton, IL
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 11/2/2017
Illinois CancerCare - Princeton
944
mi
from 02139
Princeton, IL
Click here to add this to my saved trials